Reciprocal tariffs increased import levies while stock slumps were reported following earnings releases and disappointing biotech trial results.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Reciprocal tariffs increased import levies while stock slumps were reported following earnings releases and disappointing biotech trial results.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- McDonald's, Starbucks, and Sweetgreen reported consecutive quarters of sales declines amid economic uncertainty from a trade war.Sub-event
- Disappointing drug data and narrowed revenue forecasts caused stock declines for Eli Lilly and cybersecurity stocks.Sub-event
Tariffs increased import levies, and stock slumps occurred due to earnings and disappointing drug trial results.1 source
Keep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
Fortinet
network security corporation
-
Eli Lilly and Company
American pharmaceutical company
Coverage
Newest first; wire copies grouped- InvestopediaS&P 500 Gains and Losses Today: Apple Stock Climbs; Eli Lilly Slumps After Disappointing Trial Results The S&P 500 slid 0.1% on Thursday, Aug. 7, 2025, as new tariffs took effect, raising import duti